MedMij:V1.0 Sandbox: verschil tussen versies
Naar navigatie springen
Naar zoeken springen
Regel 1: | Regel 1: | ||
− | |||
− | + | __NUMBEREDHEADINGS__ | |
+ | {{IssueBox|Deze pagina is nog in bewerking}} | ||
+ | [[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]] | ||
+ | =Addenda voor inhoudelijke gegevens= | ||
+ | ===Patiënt I. XXX_Jangi=== | ||
+ | <section begin=XXX_Jangi /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
− | = | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | + | |colspan="3"|Naamgegevens | |
+ | |style="background-color: white;"|I. XXX_Jangi | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Adresgegevens | ||
+ | |style="background-color: white;"|Knolweg 1002 9999ZZ Stitswerd | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Telefoonnummers | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Telefoonnummer | ||
+ | |style="background-color: white;"|+31612345678 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Nummer soort | ||
+ | |style="background-color: white;"|Mobiel telefoonnummer (code = 'MC' in codeSystem '2.16.840.1.113883.5.1119') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Patient identificatienummer | ||
+ | |style="background-color: white;"|999911727 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Patient identificatienummer | ||
+ | |style="background-color: white;"|10009 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geboortedatum | ||
+ | |style="background-color: white;"|2 aug 1964 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geslacht | ||
+ | |style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') | ||
+ | |}<section end=XXX_Jangi /><section begin=DG_XXX_Jangi /> | ||
+ | ====Documentgegevens XXX_Jangi ==== | ||
− | == | + | {| class="wikitable" width="85%" |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Documentgegevens | |
− | + | |-style="background-color: #1F497D;; color: white; text-align:left;" | |
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
− | == | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | + | |colspan="4"|Document datum | |
− | + | |style="background-color: white;"|T | |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur - zorgaanbieder | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="11"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Adresgegevens | ||
+ | |style="background-color: white;"|Straat 5 1598FG Utrecht | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Telefoonnummers | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Telefoonnummer | ||
+ | |style="background-color: white;"|+31703655424 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Nummer soort | ||
+ | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem '2.16.840.1.113883.5.1119') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Email adressen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Email adres | ||
+ | |style="background-color: white;"|info@apotheekgullegaper.com | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Email soort | ||
+ | |style="background-color: white;"|Zakelijk e-mailadres (code = 'WP' in codeSystem '2.16.840.1.113883.5.1119') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verificatie patient | ||
+ | |style="background-color: white;"|Nee | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verificatie zorgverlener | ||
+ | |style="background-color: white;"|Nee | ||
+ | |}<section end=DG_XXX_Jangi /><section begin=MBH_MBH_MO_123_1 /> | ||
+ | ====Medicamenteuze behandeling MBH_MO_123_1 ==== | ||
− | = | + | {| class="wikitable" width="85%" |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatie gebruik | |
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
− | == | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | + | |colspan="4"|Identificatie | |
− | + | |style="background-color: white;"|MBH_MO_123_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 10:57 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 3 dagen, gedurende 3 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Product naam | ||
+ | |style="background-color: white;"|Ibuprofen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 3 dagen, gedurende 3 dagen, 4 maal per dag 1 tablet, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|4 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toelichting | ||
+ | |style="background-color: white;"|Pijn | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_1 | ||
+ | |}<section end=MBH_MBH_MO_123_1 /><section begin=MBH_MBH_MO_123_2 /> | ||
+ | ====Medicamenteuze behandeling MBH_MO_123_2 ==== | ||
− | == | + | {| class="wikitable" width="85%" |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | |
− | + | |-style="background-color: #1F497D;; color: white; text-align:left;" | |
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 6 dagen, om 11:55 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 6 dagen, tot nader order | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel | ||
+ | |style="background-color: white;"|Emovate zalf 0,5 mg/g (code = '400629' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 6 dagen, tot nader order, eerst 2 maal per dag zalf gedurende 7 dagen, daarna 1 maal per dag zalf gedurende 7 dagen, daarna 3 maal per week zalf gedurende 7 dagen, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 1 | ||
+ | |style="background-color: white;"|eerst gedurende 7 dagen 2 maal per dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 2 | ||
+ | |style="background-color: white;"|dan gedurende 7 dagen 1 maal per dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 3 | ||
+ | |style="background-color: white;"|dan gedurende 7 dagen 3 maal per week | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toelichting | ||
+ | |style="background-color: white;"|Eczeem oogleden | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_2 | ||
+ | |}<section end=MBH_MBH_MO_123_2 /><section begin=MBH_MBH_MO_123_3 /> | ||
+ | ====Medicamenteuze behandeling MBH_MO_123_3 ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 15 dagen, om 09:13 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 15 dagen, gedurende 4 weken | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
+ | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel | ||
+ | |style="background-color: white;"|Glimepiride tablet 3mg (code = '44458' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 15 dagen, gedurende 4 weken, 1 maal per dag 2 tabletten, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 2 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toelichting | ||
+ | |style="background-color: white;"|Exact 4 weken | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_3 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_3_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 14 dagen, om 15:55 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 14 dagen, tot en met T+ 13 dagen, om 23:59 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel | ||
+ | |style="background-color: white;"|Glimepiride activis tablet 3mg (code = '1753029' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 14 dagen, tot en met T+ 13 dagen, om 23:59, 1 maal per dag 2 tabletten, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 2 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_MO_123_3_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_3 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 12:58 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 10 dagen, tot en met T+ 1 dag, om 23:59 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Product naam | ||
+ | |style="background-color: white;"|Glimepiride | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 10 dagen, tot en met T+ 1 dag, om 23:59, 1 maal per dag 1 tablet | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_3 | ||
+ | |}<section end=MBH_MBH_MO_123_3 /><section begin=MBH_MBH_MO_123_4 /> | ||
+ | ====Medicamenteuze behandeling MBH_MO_123_4 ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 60 dagen, om 09:13 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 60 dagen, tot nader order | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
+ | |style="background-color: white;"|I. Ternist - Medisch specialisten, inwendige geneeskunde. Antonius | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel | ||
+ | |style="background-color: white;"|Insuline glargine 100e/ml injvlst (code = '121312' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 60 dagen, tot nader order, 1 maal per dag 10IE, SUBCUTAAN | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 10 internationale eenheid | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_4 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 60 dagen, om 15:55 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 604 dagen, tot nader order | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |style="background-color: white;"|Poliapotheek Antonius | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel | ||
+ | |style="background-color: white;"|LANTUS SOLOSTAR INJ 100E/ML PEN 3ML (code = '1859226' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 604 dagen, tot nader order, Elke dag om 9 uur 10IE, subcutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|elke dag om 10 internationale eenheid | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_MO_123_4_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_4 | ||
+ | |}<section end=MBH_MBH_MO_123_4 /><section begin=MBH_MBH_MO_123_5 /> | ||
+ | ====Medicamenteuze behandeling MBH_MO_123_5 ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_5_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 36 dagen, om 15:55 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 36 dagen, gedurende 90 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |style="background-color: white;"|Poliapotheek Antonius | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel | ||
+ | |style="background-color: white;"|PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 8MG (code = '2105594' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 36 dagen, gedurende 90 dagen, 1 maal per dag 1 tablet, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_5 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_5_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Registratiedatum | ||
+ | |style="background-color: white;"|T- 33 dagen, om 13:58 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|false | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|false | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 36 dagen, tot nader order | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Stoptype | ||
+ | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel | ||
+ | |style="background-color: white;"|PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 8MG (code = '2105594' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 36 dagen, tot nader order, 1 maal per dag 1 tablet, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gerelateerde afspraak : TA | ||
+ | |style="background-color: white;"|MBH_MO_123_5_TA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Reden wijzigen of stoppen gebruik | ||
+ | |style="background-color: white;"|(Mogelijke) bijwerking (code = '7' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toelichting | ||
+ | |style="background-color: white;"|Gestopt vanwege bijwerkingen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_5 | ||
+ | |}<section end=MBH_MBH_MO_123_5 /><section begin=MBH_MBH_MO_123_6 /> | ||
+ | ====Medicamenteuze behandeling MBH_MO_123_6 ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_6_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 728 dagen, om 09:13 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 728 dagen, tot nader order | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
+ | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel | ||
+ | |style="background-color: white;"|Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 728 dagen, tot nader order, 1 maal per dag 1 tablet ‘s avonds, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_6 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_6_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 323 dagen, om 15:55 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 323 dagen, tot nader order | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |style="background-color: white;"|Poliapotheek Antonius | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel | ||
+ | |style="background-color: white;"|SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 323 dagen, tot nader order, 1 maal per dag 2 tabletten ‘s avonds, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 2 stuks 's avonds | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_MO_123_6_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_6 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_6_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Registratiedatum | ||
+ | |style="background-color: white;"|T- 248 dagen, om 09:00 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|false | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 248 dagen, tot nader order | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel | ||
+ | |style="background-color: white;"|SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 248 dagen, tot nader order, 1 maal per dag 12 tablet ‘s avonds, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Auteur | ||
+ | |style="background-color: white;"|Zorgverlener: I. Ternist - Medisch specialisten, inwendige geneeskunde. Antonius | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|false | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toelichting | ||
+ | |style="background-color: white;"|Patiënt gebruikt niet volgens voorschrift | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_6 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_6_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Registratiedatum | ||
+ | |style="background-color: white;"|T- 172 dagen, om 15:37 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|false | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 248 dagen, tot en met T- 173 dagen, om 23:59 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel | ||
+ | |style="background-color: white;"|SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 248 dagen, tot en met T- 173 dagen, om 23:59, 1 maal per dag 1 tablet ‘s avonds, oraal, gestopt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_MO_123_6_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gerelateerde afspraak : TA | ||
+ | |style="background-color: white;"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toelichting | ||
+ | |style="background-color: white;"|Veel last van jeuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_6 | ||
+ | |}<section end=MBH_MBH_MO_123_6 /><section begin=MBH_MBH_MO_123_7 /> | ||
+ | ====Medicamenteuze behandeling MBH_MO_123_7 ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_7_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T+ 3 dagen, tot en met T+ 17 dagen, om 23:59 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
+ | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel | ||
+ | |style="background-color: white;"|Flucloxacilline capsule 500mg (code = '5274' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T+ 3 dagen, tot en met T+ 17 dagen, om 23:59, Elke 8 uur 1 capsule, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_7 | ||
+ | |}<section end=MBH_MBH_MO_123_7 /><section begin=MBH_MBH_MO_123_8 /> | ||
+ | ====Medicamenteuze behandeling MBH_MO_123_8 ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_8_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 28 dagen, om 11:50 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 29 dagen, om 23:59 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Stoptype | ||
+ | |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |style="background-color: white;"|Poliapotheek Antonius | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Reden afspraak | ||
+ | |style="background-color: white;"|Beleidswijziging | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel | ||
+ | |style="background-color: white;"|Atorvastatine ranbaxy tablet filmomhuld 40 mg (code = '2230879' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 29 dagen, om 23:59, 1 maal per dag 2 tabletten ‘s avonds, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 2 stuks 's avonds | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_MO_123_8_MA_3 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_8 | ||
+ | |}<section end=MBH_MBH_MO_123_8 /><section begin=MBH_MBH_MO_123_9 /> | ||
+ | ====Medicamenteuze behandeling MBH_MO_123_9 ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_9_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 45 dagen, om 11:50 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 31 dagen, om 23:59 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
+ | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel | ||
+ | |style="background-color: white;"|Flucloxacilline capsule 500mg (code = '5274' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 31 dagen, om 23:59, 1 keer per exact 8 uur 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|exact iedere 8 uur 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_9 | ||
+ | |}<section end=MBH_MBH_MO_123_9 /><section begin=MBH_MBH_MO_123_10 /> | ||
+ | ====Medicamenteuze behandeling MBH_MO_123_10 ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_10_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 36 dagen, om 15:50 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 56 dagen, tot en met T- 37 dagen, om 23:59 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Stoptype | ||
+ | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |style="background-color: white;"|Poliapotheek Antonius | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Reden afspraak | ||
+ | |style="background-color: white;"|Geen of onvoldoende effect | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel | ||
+ | |style="background-color: white;"|PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 4MG (code = '2105586' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 56 dagen, tot en met T- 37 dagen, om 23:59, 1 maal per dag 1 tablet ‘s morgens, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk 's ochtends | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_MO_123_10 | ||
+ | |}<section end=MBH_MBH_MO_123_10 /> |
Versie van 5 nov 2018 18:50
Deze pagina is nog in bewerking |
1 Addenda voor inhoudelijke gegevens
1.1 Patiënt I. XXX_Jangi
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | I. XXX_Jangi | ||
Adresgegevens | Knolweg 1002 9999ZZ Stitswerd | ||
Telefoonnummers | |||
Telefoonnummer | +31612345678 | ||
Nummer soort | Mobiel telefoonnummer (code = 'MC' in codeSystem '2.16.840.1.113883.5.1119') | ||
Patient identificatienummer | 999911727 [BSN] | ||
Patient identificatienummer | 10009 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 2 aug 1964 | ||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
1.1.1 Documentgegevens XXX_Jangi
Documentgegevens | ||||
Gegevenselement | Waarde | |||
Document datum | T | |||
Auteur - zorgaanbieder | ||||
Organisatie naam | Apotheek de Gulle Gaper | |||
Adresgegevens | Straat 5 1598FG Utrecht | |||
Telefoonnummers | ||||
Telefoonnummer | +31703655424 | |||
Nummer soort | Zakelijk telefoonnummer (code = 'WP' in codeSystem '2.16.840.1.113883.5.1119') | |||
Email adressen | ||||
Email adres | info@apotheekgullegaper.com | |||
Email soort | Zakelijk e-mailadres (code = 'WP' in codeSystem '2.16.840.1.113883.5.1119') | |||
Verificatie patient | Nee | |||
Verificatie zorgverlener | Nee |
1.1.2 Medicamenteuze behandeling MBH_MO_123_1
Medicatie gebruik | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Registratiedatum | T, om 10:57 | |||
Gebruik indicator | true | |||
Gebruiksperiode | Vanaf T- 3 dagen, gedurende 3 dagen | |||
Geneesmiddel - Product specificatie | ||||
Product naam | Ibuprofen | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 3 dagen, gedurende 3 dagen, 4 maal per dag 1 tablet, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 4 maal per dag 1 stuk | |||
Auteur | Patiënt | |||
Kopie indicator | true | |||
Toelichting | Pijn | |||
MBH identificatie | MBH_MO_123_1 |
1.1.3 Medicamenteuze behandeling MBH_MO_123_2
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Afspraakdatum | T- 6 dagen, om 11:55 | |||
Gebruiksperiode | Vanaf T- 6 dagen, tot nader order | |||
Verstrekker | Apotheek De Gulle Gaper | |||
Geneesmiddel | Emovate zalf 0,5 mg/g (code = '400629' in codeSystem 'G-Standaard HPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 6 dagen, tot nader order, eerst 2 maal per dag zalf gedurende 7 dagen, daarna 1 maal per dag zalf gedurende 7 dagen, daarna 3 maal per week zalf gedurende 7 dagen, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie 1 | eerst gedurende 7 dagen 2 maal per dag | |||
Doseerinstructie 2 | dan gedurende 7 dagen 1 maal per dag | |||
Doseerinstructie 3 | dan gedurende 7 dagen 3 maal per week | |||
Toelichting | Eczeem oogleden | |||
MBH identificatie | MBH_MO_123_2 |
1.1.4 Medicamenteuze behandeling MBH_MO_123_3
Medicatieafspraak | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Afspraakdatum | T- 15 dagen, om 09:13 | |||
Gebruiksperiode | Vanaf T- 15 dagen, gedurende 4 weken | |||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |||
Geneesmiddel | Glimepiride tablet 3mg (code = '44458' in codeSystem 'G-Standaard PRK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 15 dagen, gedurende 4 weken, 1 maal per dag 2 tabletten, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Kopie indicator | true | |||
Toelichting | Exact 4 weken | |||
MBH identificatie | MBH_MO_123_3 |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_3_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Afspraakdatum | T- 14 dagen, om 15:55 | |||
Gebruiksperiode | Vanaf T- 14 dagen, tot en met T+ 13 dagen, om 23:59 | |||
Verstrekker | Apotheek De Gulle Gaper | |||
Geneesmiddel | Glimepiride activis tablet 3mg (code = '1753029' in codeSystem 'G-Standaard HPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 14 dagen, tot en met T+ 13 dagen, om 23:59, 1 maal per dag 2 tabletten, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie naar medicatieafspraak | MBH_MO_123_3_MA_1 | |||
MBH identificatie | MBH_MO_123_3 |
Medicatie gebruik | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Registratiedatum | T, om 12:58 | |||
Gebruik indicator | true | |||
Gebruiksperiode | Vanaf T- 10 dagen, tot en met T+ 1 dag, om 23:59 | |||
Geneesmiddel - Product specificatie | ||||
Product naam | Glimepiride | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 10 dagen, tot en met T+ 1 dag, om 23:59, 1 maal per dag 1 tablet | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Auteur | Patiënt | |||
Kopie indicator | true | |||
MBH identificatie | MBH_MO_123_3 |
1.1.5 Medicamenteuze behandeling MBH_MO_123_4
Medicatieafspraak | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Afspraakdatum | T- 60 dagen, om 09:13 | |||
Gebruiksperiode | Vanaf T- 60 dagen, tot nader order | |||
Voorschrijver | I. Ternist - Medisch specialisten, inwendige geneeskunde. Antonius | |||
Geneesmiddel | Insuline glargine 100e/ml injvlst (code = '121312' in codeSystem 'G-Standaard PRK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 60 dagen, tot nader order, 1 maal per dag 10IE, SUBCUTAAN | |||
Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 10 internationale eenheid | |||
Kopie indicator | true | |||
MBH identificatie | MBH_MO_123_4 |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Afspraakdatum | T- 60 dagen, om 15:55 | |||
Gebruiksperiode | Vanaf T- 604 dagen, tot nader order | |||
Verstrekker | Poliapotheek Antonius | |||
Geneesmiddel | LANTUS SOLOSTAR INJ 100E/ML PEN 3ML (code = '1859226' in codeSystem 'G-Standaard HPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 604 dagen, tot nader order, Elke dag om 9 uur 10IE, subcutaan | |||
Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | elke dag om 10 internationale eenheid | |||
Kopie indicator | true | |||
Relatie naar medicatieafspraak | MBH_MO_123_4_MA_1 | |||
MBH identificatie | MBH_MO_123_4 |
1.1.6 Medicamenteuze behandeling MBH_MO_123_5
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_5_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Afspraakdatum | T- 36 dagen, om 15:55 | |||
Gebruiksperiode | Vanaf T- 36 dagen, gedurende 90 dagen | |||
Verstrekker | Poliapotheek Antonius | |||
Geneesmiddel | PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 8MG (code = '2105594' in codeSystem 'G-Standaard HPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 36 dagen, gedurende 90 dagen, 1 maal per dag 1 tablet, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Kopie indicator | true | |||
MBH identificatie | MBH_MO_123_5 |
Medicatie gebruik | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_5_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Registratiedatum | T- 33 dagen, om 13:58 | |||
Gebruik indicator | false | |||
Volgens afspraak indicator | false | |||
Gebruiksperiode | Vanaf T- 36 dagen, tot nader order | |||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |||
Geneesmiddel | PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 8MG (code = '2105594' in codeSystem 'G-Standaard HPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 36 dagen, tot nader order, 1 maal per dag 1 tablet, oraal | |||
Gerelateerde afspraak : TA | MBH_MO_123_5_TA_1 | |||
Auteur | Patiënt | |||
Reden wijzigen of stoppen gebruik | (Mogelijke) bijwerking (code = '7' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | |||
Kopie indicator | true | |||
Toelichting | Gestopt vanwege bijwerkingen | |||
MBH identificatie | MBH_MO_123_5 |
1.1.7 Medicamenteuze behandeling MBH_MO_123_6
Medicatieafspraak | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_6_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Afspraakdatum | T- 728 dagen, om 09:13 | |||
Gebruiksperiode | Vanaf T- 728 dagen, tot nader order | |||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |||
Geneesmiddel | Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 728 dagen, tot nader order, 1 maal per dag 1 tablet ‘s avonds, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk 's avonds | |||
Kopie indicator | true | |||
MBH identificatie | MBH_MO_123_6 |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_6_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Afspraakdatum | T- 323 dagen, om 15:55 | |||
Gebruiksperiode | Vanaf T- 323 dagen, tot nader order | |||
Verstrekker | Poliapotheek Antonius | |||
Geneesmiddel | SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 323 dagen, tot nader order, 1 maal per dag 2 tabletten ‘s avonds, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks 's avonds | |||
Kopie indicator | true | |||
Relatie naar medicatieafspraak | MBH_MO_123_6_MA_1 | |||
MBH identificatie | MBH_MO_123_6 |
Medicatie gebruik | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_6_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Registratiedatum | T- 248 dagen, om 09:00 | |||
Gebruik indicator | true | |||
Volgens afspraak indicator | false | |||
Gebruiksperiode | Vanaf T- 248 dagen, tot nader order | |||
Geneesmiddel | SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 248 dagen, tot nader order, 1 maal per dag 12 tablet ‘s avonds, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk 's avonds | |||
Auteur | Zorgverlener: I. Ternist - Medisch specialisten, inwendige geneeskunde. Antonius | |||
Kopie indicator | false | |||
Toelichting | Patiënt gebruikt niet volgens voorschrift | |||
MBH identificatie | MBH_MO_123_6 |
Medicatie gebruik | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_6_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Registratiedatum | T- 172 dagen, om 15:37 | |||
Gebruik indicator | true | |||
Volgens afspraak indicator | false | |||
Gebruiksperiode | Vanaf T- 248 dagen, tot en met T- 173 dagen, om 23:59 | |||
Geneesmiddel | SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 248 dagen, tot en met T- 173 dagen, om 23:59, 1 maal per dag 1 tablet ‘s avonds, oraal, gestopt | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk 's avonds | |||
Gerelateerde afspraak : MA | MBH_MO_123_6_MA_1 | |||
Gerelateerde afspraak : TA | ||||
Auteur | Patiënt | |||
Kopie indicator | ||||
Toelichting | Veel last van jeuk | |||
MBH identificatie | MBH_MO_123_6 |
1.1.8 Medicamenteuze behandeling MBH_MO_123_7
Medicatieafspraak | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_7_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Gebruiksperiode | Vanaf T+ 3 dagen, tot en met T+ 17 dagen, om 23:59 | |||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |||
Geneesmiddel | Flucloxacilline capsule 500mg (code = '5274' in codeSystem 'G-Standaard PRK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T+ 3 dagen, tot en met T+ 17 dagen, om 23:59, Elke 8 uur 1 capsule, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Kopie indicator | true | |||
MBH identificatie | MBH_MO_123_7 |
1.1.9 Medicamenteuze behandeling MBH_MO_123_8
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_8_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Afspraakdatum | T- 28 dagen, om 11:50 | |||
Gebruiksperiode | Vanaf T- 45 dagen, tot en met T- 29 dagen, om 23:59 | |||
Stoptype | Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |||
Verstrekker | Poliapotheek Antonius | |||
Reden afspraak | Beleidswijziging | |||
Geneesmiddel | Atorvastatine ranbaxy tablet filmomhuld 40 mg (code = '2230879' in codeSystem 'G-Standaard HPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 45 dagen, tot en met T- 29 dagen, om 23:59, 1 maal per dag 2 tabletten ‘s avonds, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks 's avonds | |||
Kopie indicator | true | |||
Relatie naar medicatieafspraak | MBH_MO_123_8_MA_3 | |||
MBH identificatie | MBH_MO_123_8 |
1.1.10 Medicamenteuze behandeling MBH_MO_123_9
Medicatieafspraak | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_9_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Afspraakdatum | T- 45 dagen, om 11:50 | |||
Gebruiksperiode | Vanaf T- 45 dagen, tot en met T- 31 dagen, om 23:59 | |||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |||
Geneesmiddel | Flucloxacilline capsule 500mg (code = '5274' in codeSystem 'G-Standaard PRK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 45 dagen, tot en met T- 31 dagen, om 23:59, 1 keer per exact 8 uur 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | exact iedere 8 uur 1 stuk | |||
Kopie indicator | true | |||
MBH identificatie | MBH_MO_123_9 |
1.1.11 Medicamenteuze behandeling MBH_MO_123_10
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_MO_123_10_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Afspraakdatum | T- 36 dagen, om 15:50 | |||
Gebruiksperiode | Vanaf T- 56 dagen, tot en met T- 37 dagen, om 23:59 | |||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |||
Verstrekker | Poliapotheek Antonius | |||
Reden afspraak | Geen of onvoldoende effect | |||
Geneesmiddel | PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 4MG (code = '2105586' in codeSystem 'G-Standaard HPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T- 56 dagen, tot en met T- 37 dagen, om 23:59, 1 maal per dag 1 tablet ‘s morgens, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk 's ochtends | |||
Kopie indicator | true | |||
MBH identificatie | MBH_MO_123_10 |